NR1H4 (nuclear receptor subfamily 1 group H member 4)
|
Gene
|
Entrez ID
Entrez Gene ID - the GENE ID in NCBI Gene database.
|
9971 |
Gene nameGene Name - the full gene name approved by the HGNC.
|
Nuclear receptor subfamily 1 group H member 4 |
Gene symbolGene Symbol - the official gene symbol approved by the HGNC, which is a short abbreviated form of the gene name.
|
NR1H4 |
SynonymsGene synonyms aliases
|
BAR, FXR, HRR-1, HRR1, PFIC5, RIP14 |
ChromosomeChromosome number
|
12 |
Chromosome locationChromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
|
12q23.1 |
SummarySummary of gene provided in NCBI Entrez Gene.
|
This gene encodes a ligand-activated transcription factor that shares structural features in common with nuclear hormone receptor family members. This protein functions as a receptor for bile acids, and when bound to bile acids, binds to DNA and regulates |
SNPsSNP information provided by dbSNP.
|
SNP ID |
Visualize variation |
Clinical significance |
Consequence |
rs113090017 |
C>A,G,T |
Pathogenic |
Synonymous variant, non coding transcript variant, stop gained, intron variant, coding sequence variant, missense variant |
rs137946171 |
G>A |
Conflicting-interpretations-of-pathogenicity |
Non coding transcript variant, coding sequence variant, synonymous variant |
rs140648896 |
T>C |
Conflicting-interpretations-of-pathogenicity |
Synonymous variant, genic upstream transcript variant, non coding transcript variant, coding sequence variant |
rs770757947 |
->A |
Likely-pathogenic |
Downstream transcript variant, coding sequence variant, non coding transcript variant, frameshift variant, genic downstream transcript variant |
rs879255644 |
->AAA |
Pathogenic |
Inframe insertion, non coding transcript variant, coding sequence variant |
rs1322754256 |
C>A,T |
Conflicting-interpretations-of-pathogenicity |
Non coding transcript variant, coding sequence variant, missense variant, synonymous variant |
rs1555335324 |
C>T |
Pathogenic |
Stop gained, non coding transcript variant, coding sequence variant, intron variant |
rs1555335782 |
G>A |
Likely-pathogenic |
Splice donor variant |
rs1566464880 |
A>G |
Likely-pathogenic |
Missense variant, coding sequence variant, splice acceptor variant, non coding transcript variant |
rs1593114820 |
C>- |
Likely-pathogenic |
Coding sequence variant, non coding transcript variant, genic downstream transcript variant, frameshift variant |
|
miRNAmiRNA information provided by mirtarbase database.
|
|
Transcription factors
|
|
Gene ontology (GO)Gene ontology information of associated ontologies with gene provided by GO database.
|
GO ID |
Ontology |
Definition |
Evidence |
Reference |
GO:0000122 |
Process |
Negative regulation of transcription by RNA polymerase II |
IBA |
21873635 |
GO:0000122 |
Process |
Negative regulation of transcription by RNA polymerase II |
ISS |
21757002 |
GO:0000785 |
Component |
Chromatin |
IC |
27471003 |
GO:0000785 |
Component |
Chromatin |
ISA |
|
GO:0000791 |
Component |
Euchromatin |
IDA |
21757002 |
GO:0000977 |
Function |
RNA polymerase II transcription regulatory region sequence-specific DNA binding |
IDA |
23767959 |
GO:0000978 |
Function |
RNA polymerase II cis-regulatory region sequence-specific DNA binding |
IBA |
21873635 |
GO:0000978 |
Function |
RNA polymerase II cis-regulatory region sequence-specific DNA binding |
IDA |
21757002 |
GO:0000981 |
Function |
DNA-binding transcription factor activity, RNA polymerase II-specific |
IDA |
21757002 |
GO:0000981 |
Function |
DNA-binding transcription factor activity, RNA polymerase II-specific |
ISA |
|
GO:0001080 |
Process |
Nitrogen catabolite activation of transcription from RNA polymerase II promoter |
IC |
21757002 |
GO:0001228 |
Function |
DNA-binding transcription activator activity, RNA polymerase II-specific |
IDA |
21757002, 24211198, 27471003 |
GO:0001678 |
Process |
Cellular glucose homeostasis |
IEA |
|
GO:0003700 |
Function |
DNA-binding transcription factor activity |
TAS |
9223286 |
GO:0004879 |
Function |
Nuclear receptor activity |
IBA |
21873635 |
GO:0004879 |
Function |
Nuclear receptor activity |
IDA |
23767959, 27471003 |
GO:0004879 |
Function |
Nuclear receptor activity |
ISS |
21757002 |
GO:0005515 |
Function |
Protein binding |
IPI |
12917342, 14684751, 14701856, 15317749, 19833092, 21532585, 22345554 |
GO:0005654 |
Component |
Nucleoplasm |
TAS |
|
GO:0006357 |
Process |
Regulation of transcription by RNA polymerase II |
IDA |
10334992 |
GO:0006367 |
Process |
Transcription initiation from RNA polymerase II promoter |
TAS |
|
GO:0006954 |
Process |
Inflammatory response |
IEA |
|
GO:0007043 |
Process |
Cell-cell junction assembly |
IEA |
|
GO:0007219 |
Process |
Notch signaling pathway |
IEA |
|
GO:0008206 |
Process |
Bile acid metabolic process |
IEA |
|
GO:0008270 |
Function |
Zinc ion binding |
IEA |
|
GO:0010804 |
Process |
Negative regulation of tumor necrosis factor-mediated signaling pathway |
IEA |
|
GO:0010903 |
Process |
Negative regulation of very-low-density lipoprotein particle remodeling |
IDA |
27471003 |
GO:0010988 |
Process |
Regulation of low-density lipoprotein particle clearance |
IDA |
12660231 |
GO:0015721 |
Process |
Bile acid and bile salt transport |
TAS |
|
GO:0016922 |
Function |
Nuclear receptor binding |
TAS |
21757002 |
GO:0030154 |
Process |
Cell differentiation |
IBA |
21873635 |
GO:0030522 |
Process |
Intracellular receptor signaling pathway |
ISS |
|
GO:0032052 |
Function |
Bile acid binding |
IBA |
21873635 |
GO:0032052 |
Function |
Bile acid binding |
ISS |
21757002 |
GO:0032052 |
Function |
Bile acid binding |
TAS |
21757002 |
GO:0032088 |
Process |
Negative regulation of NF-kappaB transcription factor activity |
IEA |
|
GO:0032620 |
Process |
Interleukin-17 production |
IDA |
21242261 |
GO:0032689 |
Process |
Negative regulation of interferon-gamma production |
IDA |
21242261 |
GO:0032692 |
Process |
Negative regulation of interleukin-1 production |
IEA |
|
GO:0032703 |
Process |
Negative regulation of interleukin-2 production |
IEA |
|
GO:0032715 |
Process |
Negative regulation of interleukin-6 production |
IEA |
|
GO:0032720 |
Process |
Negative regulation of tumor necrosis factor production |
IDA |
21242261 |
GO:0034142 |
Process |
Toll-like receptor 4 signaling pathway |
IDA |
19864602 |
GO:0034162 |
Process |
Toll-like receptor 9 signaling pathway |
IEA |
|
GO:0034255 |
Process |
Regulation of urea metabolic process |
ISS |
21757002 |
GO:0034971 |
Process |
Histone H3-R17 methylation |
IDA |
15471871 |
GO:0035356 |
Process |
Cellular triglyceride homeostasis |
IDA |
20447400 |
GO:0035774 |
Process |
Positive regulation of insulin secretion involved in cellular response to glucose stimulus |
IEA |
|
GO:0038181 |
Function |
Bile acid receptor activity |
IBA |
21873635 |
GO:0038181 |
Function |
Bile acid receptor activity |
IDA |
10334992 |
GO:0038181 |
Function |
Bile acid receptor activity |
TAS |
23767959 |
GO:0038183 |
Process |
Bile acid signaling pathway |
IBA |
21873635 |
GO:0038183 |
Process |
Bile acid signaling pathway |
ISS |
|
GO:0038183 |
Process |
Bile acid signaling pathway |
TAS |
23767959 |
GO:0038185 |
Process |
Intracellular bile acid receptor signaling pathway |
IDA |
10334992 |
GO:0042632 |
Process |
Cholesterol homeostasis |
IEA |
|
GO:0042742 |
Process |
Defense response to bacterium |
IEA |
|
GO:0043066 |
Process |
Negative regulation of apoptotic process |
IDA |
20447400 |
GO:0043124 |
Process |
Negative regulation of I-kappaB kinase/NF-kappaB signaling |
IDA |
21242261 |
GO:0043235 |
Component |
Receptor complex |
IDA |
10334992 |
GO:0043565 |
Function |
Sequence-specific DNA binding |
IDA |
12815072 |
GO:0045087 |
Process |
Innate immune response |
IEA |
|
GO:0045893 |
Process |
Positive regulation of transcription, DNA-templated |
IDA |
27471003 |
GO:0045944 |
Process |
Positive regulation of transcription by RNA polymerase II |
IBA |
21873635 |
GO:0045944 |
Process |
Positive regulation of transcription by RNA polymerase II |
IDA |
23767959 |
GO:0045944 |
Process |
Positive regulation of transcription by RNA polymerase II |
IMP |
21757002 |
GO:0046628 |
Process |
Positive regulation of insulin receptor signaling pathway |
IEA |
|
GO:0046965 |
Function |
Retinoid X receptor binding |
IEA |
|
GO:0050728 |
Process |
Negative regulation of inflammatory response |
IBA |
21873635 |
GO:0055089 |
Process |
Fatty acid homeostasis |
IEA |
|
GO:0061178 |
Process |
Regulation of insulin secretion involved in cellular response to glucose stimulus |
IDA |
20447400 |
GO:0070857 |
Process |
Regulation of bile acid biosynthetic process |
TAS |
21757002 |
GO:0071222 |
Process |
Cellular response to lipopolysaccharide |
IEA |
|
GO:0071398 |
Process |
Cellular response to fatty acid |
IDA |
20447400 |
GO:0071417 |
Process |
Cellular response to organonitrogen compound |
ISS |
21757002 |
GO:0071638 |
Process |
Negative regulation of monocyte chemotactic protein-1 production |
IEA |
|
GO:0090181 |
Process |
Regulation of cholesterol metabolic process |
TAS |
21757002 |
GO:1902122 |
Function |
Chenodeoxycholic acid binding |
IDA |
10334992 |
GO:1903413 |
Process |
Cellular response to bile acid |
IDA |
10334992 |
GO:1904179 |
Process |
Positive regulation of adipose tissue development |
IEA |
|
GO:1905695 |
Process |
Positive regulation of phosphatidic acid biosynthetic process |
IDA |
23767959 |
GO:2000213 |
Process |
Positive regulation of glutamate metabolic process |
ISS |
21757002 |
GO:2001250 |
Process |
Positive regulation of ammonia assimilation cycle |
IEA |
|
|
Other IDsOther ids provides unique ids of gene in databases such as OMIM, HGNC, ENSEMBLE.
|
|
Protein
|
UniProt ID |
Q96RI1 |
Protein name |
Bile acid receptor (Farnesoid X-activated receptor) (Farnesol receptor HRR-1) (Nuclear receptor subfamily 1 group H member 4) (Retinoid X receptor-interacting protein 14) (RXR-interacting protein 14) |
Protein function |
Ligand-activated transcription factor. Receptor for bile acids (BAs) such as chenodeoxycholic acid (CDCA), lithocholic acid, deoxycholic acid (DCA) and allocholic acid (ACA). Plays a essential role in BA homeostasis through the regulation of gen |
PDB |
1OSH
,
3BEJ
,
3DCT
,
3DCU
,
3FLI
,
3FXV
,
3GD2
,
3HC5
,
3HC6
,
3L1B
,
3OKH
,
3OKI
,
3OLF
,
3OMK
,
3OMM
,
3OOF
,
3OOK
,
3P88
,
3P89
,
3RUT
,
3RUU
,
3RVF
,
4OIV
,
4QE8
,
4WVD
,
5IAW
,
5ICK
,
5Q0I
,
5Q0J
,
5Q0K
,
5Q0L
,
5Q0M
,
5Q0N
,
5Q0O
,
5Q0P
,
5Q0Q
,
5Q0R
,
5Q0S
,
5Q0T
,
5Q0U
,
5Q0V
,
5Q0W
,
5Q0X
,
5Q0Y
,
5Q0Z
,
5Q10
,
5Q11
,
5Q12
,
5Q13
,
5Q14
,
5Q15
|
Family and domains |
Pfam
Accession |
ID |
Position in sequence |
Description |
Type |
PF00105 |
zf-C4 |
135 → 204 |
Zinc finger, C4 type (two domains) |
Domain |
PF00104 |
Hormone_recep |
289 → 471 |
Ligand-binding domain of nuclear hormone receptor |
Domain |
|
Sequence |
|
Sequence length |
486 |
Interactions |
View interactions |
PathwaysPathway information has different metabolic/signaling pathways associated with genes. Each record is hyperlinked to a complete information page which also includes links to the KEGG/Reactome pathway database.
|
|
Associated diseases
|
Causal |
Disease name |
Disease term |
dbSNP ID |
References |
Cholestasis |
Cholestasis |
rs121909103, rs751511532, rs376368459, rs762702807, rs1578490102, rs1578499691, rs1578504946, rs1317656688, rs199791850, rs1452792080, rs1578491039 |
23178280, 22461449 |
Cholestasis of pregnancy |
Cholestasis of pregnancy |
rs11568372, rs121918440, rs387906527, rs72552778, rs387906528, rs72552780, rs769910565, rs188824058, rs375315619, rs754287486, rs764513998, rs759202962, rs377160065, rs1562965036, rs764296800, rs1584665400, rs1584671714, rs1187517509, rs1584684209, rs533310204, rs571555115, rs1584754706, rs1584754766, rs1584763429, rs757693457, rs1574445178, rs1584742063, rs1584750660, rs752563752 |
23142591 |
Intrahepatic cholestasis |
Progressive intrahepatic cholestasis (disorder), CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5, Progressive familial intrahepatic cholestasis type 5 |
rs121918299, rs80338722, rs80338725, rs80338719, rs80338723, rs80338726, rs72549401, rs11568372, rs1553469602, rs387907317, rs387906354, rs752919965, rs72549397, rs111033609, rs121909099, rs387906381, rs121909100, rs121909101, rs121909104, rs121909105, rs387906526, rs121918440, rs387906527, rs72552778, rs387906529, rs121918443, rs72552780, rs80338724, rs80338715, rs80338727, rs80338729, rs80338716, rs80338717, rs398122839, rs515726137, rs587777519, rs587777520, rs587777521, rs879255644, rs113090017, rs864321695, rs776869985, rs864321697, rs80338720, rs746155190, rs879255504, rs886041948, rs886042562, rs769910565, rs758069019, rs886043807, rs72549402, rs72549395, rs188824058, rs763782349, rs375315619, rs754287486, rs1057518679, rs1060499649, rs1060499579, rs1554660803, rs1554407511, rs774824767, rs771690686, rs752992432, rs1553466082, rs72549396, rs772294884, rs764513998, rs1202682161, rs759202962, rs1562774655, rs1562831765, rs1562945221, rs917981474, rs1558927163, rs765889649, rs1562976061, rs72549399, rs1459273753, rs377160065, rs1559183717, rs760750012, rs1051861187, rs1558898789, rs928915940, rs752757689, rs1584678508, rs764581483, rs1574453508, rs751511532, rs1182781290, rs376368459, rs762702807, rs1578499691, rs199791850, rs1452792080, rs1458423947, rs1584747270, rs1584750653, rs1599066459, rs1599069873, rs1599166106, rs1574462504, rs1593114820, rs1057524081, rs1588081022, rs777460754, rs1251192873, rs1588117076, rs748671901, rs139314808, rs749009273, rs1588080674, rs1588080680, rs1588127136, rs1588135086, rs757693457, rs1574445178, rs768922690, rs1584422832, rs1584433525, rs1312396424, rs1792048079, rs774411820, rs575729461 |
21633855, 26888176, 26888176 |
Liver failure |
Liver Failure |
rs118203990, rs118203991, rs118203992, rs387907022, rs201861847, rs796065037, rs759315662, rs368196005, rs796052121, rs369437593, rs367683258, rs766314948, rs368085185, rs770446752, rs753039116, rs776797592, rs1490906786, rs1562849964, rs759960319, rs776597537, rs375350359, rs1573008071, rs1601977105, rs1174791046, rs1019313682 |
|
|
Unknown |
Disease name |
Disease term |
dbSNP ID |
References |
Atherosclerosis |
Atherosclerosis |
rs699947, rs59439148 |
30996006 |
Ciliopathies |
Ciliopathies |
|
|
Cirrhosis |
Cirrhosis |
rs119465999, rs144369314, rs8056684, rs112053857, rs75998507 |
|
Crohn disease |
Crohn Disease, Regional enteritis |
rs2066847, rs2066844, rs886052047, rs5743265, rs111608429, rs104895438 |
21829567 |
Crohn`s disease of large bowel |
Crohn`s disease of large bowel |
|
21829567 |
Crohn`s disease of the ileum |
Crohn`s disease of the ileum |
|
21829567 |
Fatty liver |
Fatty Liver, Steatohepatitis |
|
29142166 |
Fibroatheroma |
Fibroatheroma |
|
30996006 |
Hypoglycemia |
Hypoglycemia |
|
|
Ileocolitis |
IIeocolitis |
|
21829567 |
Intestinal neoplasms |
Intestinal Neoplasms |
|
23178280 |
Intestinal cancer |
Intestinal Cancer |
|
23178280 |
Intrahepatic cholestasis of pregnancy |
Intrahepatic cholestasis of pregnancy |
|
|
Liver neoplasms |
Liver neoplasms |
|
30556042, 24189133, 29142166, 23178280, 24091600 |
Liver cancer |
Malignant neoplasm of liver |
|
30556042, 29142166, 24189133, 23178280, 24091600 |
Liver carcinoma |
Liver carcinoma |
|
23811326, 25496033 |
Non-alcoholic fatty liver disease |
Non-alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis |
|
29142166 |
|
|
|